Targeting apoptosis pathways in cancer by Chinese medicine

被引:239
作者
Li-Weber, Min [1 ]
机构
[1] German Canc Res Ctr, Tumor Immunol Program D030, D-69120 Heidelberg, Germany
关键词
Cancer; Apoptosis; ROS; DNA damage; NF-kappa B; MAPK; Drug; FACTOR-KAPPA-B; DOWN-REGULATION; CELL-DEATH; SUPPRESSES ANGIOGENESIS; ANTICANCER PROPERTIES; MEDIATED APOPTOSIS; GENE-EXPRESSION; TUMOR-GROWTH; TNF-ALPHA; ACTIVATION;
D O I
10.1016/j.canlet.2010.07.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The traditional Chinese medicine (TCM) uses a combination of different natural products based on practical experiences. To better understand the therapeutic functions of TCM, large efforts have been made to identify the principle constituents of TCM and to unravel the molecular mechanisms behind the efficacy observed. This review aims to summarize research results obtained from the most intensively studied TCM phytochemical compounds namely the alkaloids Berberine, Evodiamine; anthraquinones Emodin, Aloe-emodin, Rhein; the terpenoids Artemisinin, Celastrol, Triptolide; the flavones Apigenin, Chrysin, Wogonin, Baicalein; and the cyclopenta[b]benzofuran derivatives Rocaglamide. Most of them have been originally identified as anti-inflammatory and anti-viral reagents and are now known to also possess anti-tumor activities by targeting the apoptosis pathways in cancer. This review also intends to give an overview of the mechanisms of action identified so far. These breakthrough findings may have important implications for targeted-cancer therapy and for modernization of TCM. (C)2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:304 / 312
页数:9
相关论文
共 67 条
[1]   Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca2+-dependent apoptosis [J].
Baumann, Sven ;
Fas, Stefanie C. ;
Giaisi, Marco ;
Mueller, Wolfgang W. ;
Merling, Anette ;
Guelow, Karsten ;
Edler, Lutz ;
Krammer, Peter H. ;
Li-Weber, Min .
BLOOD, 2008, 111 (04) :2354-2363
[2]   Bid: a Bax-like BH3 protein [J].
Billen, L. P. ;
Shamas-Din, A. ;
Andrews, D. W. .
ONCOGENE, 2008, 27 (Suppl 1) :S93-S104
[3]  
Bleumink M., 2010, CELL DEATH IN PRESS
[4]   OPINION γH2AX and cancer [J].
Bonner, William M. ;
Redon, Christophe E. ;
Dickey, Jennifer S. ;
Nakamura, Asako J. ;
Sedelnikova, Olga A. ;
Solier, Stephanie ;
Pommier, Yves .
NATURE REVIEWS CANCER, 2008, 8 (12) :957-967
[5]   Progress towards the discovery of xanthine oxidase inhibitors [J].
Borges, F ;
Fernandes, E ;
Roleira, F .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (02) :195-217
[6]   Concepts of activated T cell death [J].
Brenner, Dirk ;
Krammer, Peter H. ;
Arnold, Ruediger .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (01) :52-64
[7]   Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance [J].
Bubici, C. ;
Papa, S. ;
Dean, K. ;
Franzoso, G. .
ONCOGENE, 2006, 25 (51) :6731-6748
[8]   CD95 promotes tumour growth [J].
Chen, Lina ;
Park, Sun-Mi ;
Tumanov, Alexei V. ;
Hau, Annika ;
Sawada, Kenjiro ;
Feig, Christine ;
Turner, Jerrold R. ;
Fu, Yang-Xin ;
Romero, Iris L. ;
Lengyel, Ernst ;
Peter, Marcus E. .
NATURE, 2010, 465 (7297) :492-496
[9]   Pharmacological evaluation of several major ingredients of Chinese herbal medicines in human hepatoma Hep3B cells [J].
Chou, CC ;
Pan, SL ;
Teng, CM ;
Guh, JH .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 19 (05) :403-412
[10]   Current insights into the regulation of programmed cell death by NF-κB [J].
Dutta, J. ;
Fan, Y. ;
Gupta, N. ;
Fan, G. ;
Gelinas, C. .
ONCOGENE, 2006, 25 (51) :6800-6816